{"id":251291,"date":"2014-04-23T15:49:19","date_gmt":"2014-04-23T19:49:19","guid":{"rendered":"http:\/\/www.eugenesis.com\/scientists-identify-cancer-specific-cell-for-potential-treatment-of-gastric-cancer\/"},"modified":"2014-04-23T15:49:19","modified_gmt":"2014-04-23T19:49:19","slug":"scientists-identify-cancer-specific-cell-for-potential-treatment-of-gastric-cancer-2","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/scientists-identify-cancer-specific-cell-for-potential-treatment-of-gastric-cancer-2.php","title":{"rendered":"Scientists identify cancer specific cell for potential treatment of gastric cancer"},"content":{"rendered":"<p><p>    PUBLIC RELEASE DATE:  <\/p>\n<p>    23-Apr-2014  <\/p>\n<p>    Contact: Kimberley Wang    <a href=\"mailto:kimberley.wang@nus.edu.sg\">kimberley.wang@nus.edu.sg<\/a>    National University of    Singapore<\/p>\n<p>    A team of scientists led by a researcher from the Cancer    Science Institute of Singapore (CSI Singapore) at the National    University of Singapore has identified the cancer specific stem    cell which causes gastric cancer. This discovery opens up the    possibility of developing new drugs for the treatment of this    disease and other types of cancers.  <\/p>\n<p>    The research group, led by Dr Chan Shing Leng, Research    Assistant Professor at CSI Singapore, demonstrated for the    first time that a cancer-specific variant of a cell surface    protein, CD44v8-10, marks gastric cancer stem cells but not    normal cells. Conceptualised by Dr Chan and Associate Professor    Jimmy So, a Senior Consultant from the Department of Surgery at    the National University Hospital Singapore, the study is also    the first to be conducted with human gastric tissue specimens    and took five years to complete. This novel study will be    published in the research journal Cancer Research, the    official journal of American Association of Cancer Research, in    May 2014.  <\/p>\n<p>    Gastric cancer is a major cause of cancer-related deaths    worldwide, with low survival and high recurrence rates for    patients with advanced disease. New therapies for the treatment    of gastric cancer are urgently needed.  <\/p>\n<p>    How CD44v8-10 serves as a biomarker  <\/p>\n<p>    Many cancer cell types express high levels of a cell surface    protein known as CD44. This protein marks cancer stem cells    that are thought to be responsible for resistance to current    cancer therapy and tumour relapse. There are many forms of CD44    and the standard form of CD44, CD44s, is found in high    abundance on normal blood cells. It was previously not known    which form of CD44 is found on cancer stem cells. This is    critical as an ideal cancer target should mark only cancer    cells but not normal cells.  <\/p>\n<p>    Research by the team and other scientists in the field has led    to the hypothesis that the growth of gastric cancer may be    driven by cancer stem cells. In this study, the researchers    analysed 53 patient tissue samples in conjunction with    patient-derived xenograft models which are derived from    intestinal type gastric cancer. The team is one of the few    groups in the world to have a relatively large collection of    patient-derived xenograft models for gastric cancer and the    first to use these models for identification of gastric cancer    stem cells. A total of eight cancer cell lines were used in    this study, including six new cell lines which were established    by the researchers.  <\/p>\n<p>    The scientists discovered a cancer-specific CD44 variant,    CD44v8-10 marks gastric cancer stem cells but not normal cells.    CD44v8-10 promotes cancer cell growth and it is significantly    more abundant in gastric tumour sites compared to normal    gastric tissue, which makes it easily detectable. The findings    results suggest that CD44v8-10 is an ideal target for    developing clinical therapeutics against gastric cancer stem    cells. As CD44v8-10 is cancer specific, it may also be used as    a biomarker for screening and diagnosis of gastric cancer. This    is significant as biomarkers for early detection of gastric    cancer are currently not available and doctors rely on    endoscopy for the screening and diagnosis of this disease.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>The rest is here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2014-04\/nuos-sic042314.php\/RS=^ADA33wj0ns91m_MMwxzvTMYvyJJIUQ-\" title=\"Scientists identify cancer specific cell for potential treatment of gastric cancer\">Scientists identify cancer specific cell for potential treatment of gastric cancer<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PUBLIC RELEASE DATE: 23-Apr-2014 Contact: Kimberley Wang <a href=\"mailto:kimberley.wang@nus.edu.sg\">kimberley.wang@nus.edu.sg<\/a> National University of Singapore A team of scientists led by a researcher from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has identified the cancer specific stem cell which causes gastric cancer. This discovery opens up the possibility of developing new drugs for the treatment of this disease and other types of cancers. The research group, led by Dr Chan Shing Leng, Research Assistant Professor at CSI Singapore, demonstrated for the first time that a cancer-specific variant of a cell surface protein, CD44v8-10, marks gastric cancer stem cells but not normal cells <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/scientists-identify-cancer-specific-cell-for-potential-treatment-of-gastric-cancer-2.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25],"tags":[],"class_list":["post-251291","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/251291"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=251291"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/251291\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=251291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=251291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=251291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}